University of Liverpool
Our funding at the University of Liverpool was concentrated on a specific area of scientific enquiry. In total, we awarded £51,406 across two grants, both of which supported research into cancer metastasis. These projects were positioned firmly within the disease modelling strand of our programme, focusing on fundamental questions about how cancer spreads rather than on immediate therapeutic application.
The Liverpool grants supported multi‑year research that aimed to deepen understanding of the biological mechanisms underlying metastatic disease. Metastasis remains one of the most challenging aspects of cancer treatment and prognosis, and that meaningful progress depends on strong foundational science. Our funding reflected a belief that investment in understanding disease behaviour is a necessary step toward future advances in prevention, diagnosis, and treatment.
We accepted that research outcomes would likely take the form of publications, models and enhanced scientific understanding rather than clear clinical products within the programme timeframe. As with much discovery‑phase research, the value lay as much in building knowledge and expertise as in generating immediately transferable results.
Our investment at Liverpool reflected our broader willingness to support foundational cancer research where clinical impact might be indirect or long‑term. Even at relatively modest scale, these grants formed part of the wider ecosystem on which later translational progress depends.
